Flavoxate (Urispas) shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Flavoxate is in a widespread shortage in Canada. 2 of 2 reported products are affected. Manufacturers have not committed to a recovery date.

A urinary antispasmodic used to relieve bladder spasms and painful or frequent urination.

Products affected

2 / 2

In shortage since

Mar 19, 2008

Reports on file

Talk to a pharmacist

Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.

Book a pharmacist appointment

Need your prescription switched?

When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.

See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage

URISPAS TAB 200MG

200MG · TABLET · PALADIN LABS INC

DIN 00728179 · since Mar 19, 2008, no end estimate

Active shortage

APO-FLAVOXATE

200MG · TABLET · APOTEX INC

DIN 02244842 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.

What's happening

Flavoxate is currently affected by 2 active shortage reports filed with Health Canada by PALADIN LABS INC, APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Flavoxate is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BD).

Recent changes

No changes recorded yet.

Common questions

What is Flavoxate used for?

A urinary antispasmodic used to relieve bladder spasms and painful or frequent urination.

When will Flavoxate be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Flavoxate in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (other urologicals, incl antispasmodics)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Dimethyl Sulfoxide (Rimso-50) No current shortage Vardenafil (Levitra) No current shortage Darifenacin (Enablex) Partial shortage 1 of 6 reported products affected Fesoterodine (Toviaz) Partial shortage 1 of 4 reported products affected · est. return Dec 10, 2027 Oxybutynin Chloride (Ditropan Xl) Partial shortage 2 of 11 reported products affected Phenazopyridine (Pyridium) Partial shortage 1 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.